PMGC (NASDAQ:ELAB – Get Free Report) released its quarterly earnings results on Friday. The company reported ($4.01) earnings per share for the quarter, FiscalAI reports. The company had revenue of $2.53 million for the quarter. PMGC had a negative return on equity of 118.83% and a negative net margin of 522.92%.
PMGC Trading Down 0.6%
Shares of ELAB traded down $0.01 during midday trading on Friday, reaching $1.58. The company had a trading volume of 33,774 shares, compared to its average volume of 707,178. PMGC has a 1-year low of $1.41 and a 1-year high of $1,344.00. The stock has a market cap of $1.28 million, a PE ratio of -0.00 and a beta of -0.27. The firm has a 50 day simple moving average of $3.26 and a 200-day simple moving average of $27.14. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 0.02.
Institutional Inflows and Outflows
An institutional investor recently bought a new stake in PMGC stock. Citadel Advisors LLC acquired a new stake in PMGC Holdings Inc. (NASDAQ:ELAB – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 20,702 shares of the company’s stock, valued at approximately $25,000. Citadel Advisors LLC owned 2.56% of PMGC at the end of the most recent quarter. Hedge funds and other institutional investors own 22.22% of the company’s stock.
Analyst Ratings Changes
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of PMGC in a report on Tuesday, September 22nd. One research analyst has rated the stock with a Sell rating. According to MarketBeat, PMGC has an average rating of “Sell”.
Read Our Latest Analysis on PMGC
About PMGC
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
Read More
- Five stocks we like better than PMGC
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
